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Vitamin A in Health and Disease
Mohd Fairulnizal Md Noh, Rathi Devi Nair Gunasegavan 
and Suraiami Mustar
Abstract
Vitamin A refers to a group of related compounds with all-trans retinol biologi-
cal activity and includes retinol, retinal, retinoic acid as well as the retinyl esters. 
Dietary source of vitamin A ranges from animal-based or plant-based foods, 
fortified food products and supplements. The vital biological roles of vitamin A 
compounds include normal cell growth, cell differentiation, vision and immu-
nology. Vitamin A status is monitored to prevent occurrence of both subclinical 
deficiency and toxicity. Vitamin deficiency or excess is determined through the 
measure of vitamin A status. Prolonged vitamin A intake at high doses is shown to 
be toxic, which leads to various health symptoms. Xerophthalmia, a dry eye condi-
tion is the most severe clinical effects known to be caused by vitamin A deficiency. 
The resulting deleterious effects on human health led to efforts of supplementation, 
food fortification and dietary diversification in combating vitamin A deficiency. 
In brief, this chapter covers on vitamin A, with focus on its general information, 
dietary recommendations, biological roles, vitamin A status assessment, deficiency 
or excess effects to human health as well as the prevention measures.
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1. Introduction
Vitamin A in health and disease chapter intends to introduce general informa-
tion of vitamin A with specific focus mainly on its dietary recommendations and its 
importance to human health. In line with this, continuous monitoring of vitamin 
A status that determines deficiency or toxicity state that could significantly affect 
human health along with prevention efforts is also described.
Vitamin A is a fat-soluble vitamin and also comprises of a group of unsaturated 
nutritional organic compounds. These compounds include preformed vitamin A that 
exist in the form of retinol (alcohol), retinal (aldehyde), retinoic acid (irreversibly 
oxidized form of retinol) and several pro-vitamin A carotenoids (mainly β–caro-
tene). The preformed vitamin A can only be obtained from the diet in food of animal 
origin and is the most abundant form of vitamin A in the human body. Retinol is 
a yellow fat-soluble substance, an absorbable form of vitamin A present in animal 
food sources. This chemical structure makes it poorly soluble in water but easily 
transferable through membrane lipid bilayers. Retinol is an alcohol and is known to 
be unstable. Vitamin A is mainly found in human tissues in the form of retinyl esters, 
which explains why the vitamin is commercially produced and administered as esters 
of retinyl acetate or palmitate. Retinyl esters will subsequently be converted into 
retinols in the small intestine [1, 2]. The pro-vitamin A comes from plant-derived 
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foods primarily in oils, fruits and vegetables. β-Carotene is the major source of 
vitamin A precursor from plants and is represented as two connected retinyl groups. 
The molecules contribute to the body’s total vitamin A level. All forms of vitamin A 
have a β-ionone ring, which is attached to an isoprenoid chain (retinyl group). Both 
of these structural moieties are essential for the vitamin to exert biological activity. 
The β-ionone ring containing carotenoids include α-carotene, β-carotene and the 
xanthophyll β-cryptoxanthin [2].
Vitamin A can be found in a variety of foods. The bioavailability of carotenoids 
in food is variable because the efficacy of metabolic processes that convert carotene 
into retinol varies from one person to another. Table 1 shows important dietary 
sources of vitamin A. Foods rich in retinol include meat, butter, retinol-enriched 
margarine, dairy products and eggs, while foods rich in β-carotene include veg-
etables and fruits (e.g. sweet potatoes, carrots, dark-green leafy vegetables, sweet 
red peppers, mangoes, melons). Several processed foods have been fortified with 
vitamin A and are good sources of the vitamin, such as cornflakes, malted milk 
powder and milk powder [2–4]. Foods containing pro-vitamin A carotenoids tend 
to have less biologically available vitamin A but are more affordable than animal 
products especially in the diets of economically deprived populations.
Retinol, in the form of retinyl esters, and pro-vitamin A carotenoids enter the 
human body as a component of nascent chylomicrons secreted into the lymphatic 
system. Most dietary retinol (in chylomicrons and chylomicron remnants) is taken 
up by the liver, which is the major site of retinol metabolism and storage. Once 
circulating retinol is absorbed from the intestine, it will bind primarily to a protein 
Food category Vitamin A (μg retinol equivalent/100g)
Meat/poultry/fish
Liver (ox/beef, chicken) 9000–16,000
Egg, whole (duck, hen) 208–304
Chicken, duck (thigh) 50–69
Fish, mackerel, Indian/Spanish 8
Vegetables
Carrot, raw 835
Sweet potato 709
Spinach 469
Broccoli 31
Fruits
Mango 54–214
Papaya 55–193
Apricot 96
Watermelon 28–68
Processed Food
Butter 200–684
Cheddar cheese 117–265
Full cream milk powder 400
Malted milk powder 711
Table 1. 
Dietary sources of vitamin A and retinol activity equivalences (adapted from [5, 6]).
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called retinol-binding protein (RBP). The RBP will enter and leave the liver several 
times daily due to its lipophilic properties in a process known as retinol recycling. 
The retinol will bind to a cellular RBP (CRBP-I or CRBP-II) and can then be esteri-
fied by enzyme lecithin: retinol acyltransferase (LRAT), which enables the vitamins 
to be interconvertible, i.e. the stored ester and circulating retinol form. The storage 
efficiency and retinol catabolism are dependent on vitamin A status. Low retinol 
stores are associated with reduced storage efficiency and decrease the absolute 
catabolic rate [2].
To express the vitamin A activity of carotenoids in diets on a common basis, a 
concept of the retinol equivalent (RE) was introduced [7]. Based on this concept, 
the relationships among food sources of vitamin A were established as shown 
below:
A new term, retinol activity equivalent (RAE), was introduced in order to 
express the activity of carotenoids after taking into account new research on 
vitamin A activity of carotenoids [8, 9]. Specific carotenoids/retinol equivalence 
ratios are defined for pro-vitamin A carotenoids, which account for the less efficient 
absorption of carotenoids and their bioconversion to retinol. Recent work has 
shown that the absorption of carotenoids, the vitamin A precursors, is only half of 
as much as that previously considered. Institute of Medicine established the follow-
ing conversion factor equivalents:
The use of SI units (weight and molar) is strongly recommended to replace the 
use of IU in many databases to decrease confusion and overcome limitations in the 
nonequivalence of the IU values for retinol and β-carotenes. The conversion factors 
to be used are as follows:
2. Biological roles of vitamin A
Vitamin A is an essential micronutrient required in small amounts by human 
throughout the life cycle to perform multiple metabolic functions. It is important 
for growth and development, the maintenance of immune function and mainte-
nance of epithelial cell integrity, good vision, reproduction as well as lipid metabo-
lism. Vitamin A is also an important antioxidant, a property shared with vitamins 
1 μg retinol = 1 μg RE
1 μg β-carotene = 0.167 μg RE
1 μg other pro-vitamin A = 0.084 μg RE
1 μg retinol = 1 μg RAE
1 μg β-carotene in oil = 0.5 μg RAE
1 μg β-carotene in mixed foods = 0.083 μg RAE
1 μg β-carotene and other pro-vitamin A carotenoids in mixed foods = 0.042 μg RAE
1 IU retinol = 0.3 μg retinol
1 IU β-carotene = 0.6 μg β-carotene
I IU retinol = 3.0 μg β-carotene
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E and C, respectively [3]. New biological functions of vitamin A such as lipid 
metabolism, insulin response, energy balance and the nervous system are continu-
ously being discovered.
2.1 Vitamin A and health importance
Vitamin A has long been known to play a critical role in vision. Night blindness 
or reduced vision ability under dim light is a very early and purely subjective symp-
tom of vitamin A deficiency (VAD). In the eye, the 11-cis retinal binds to protein, 
term opsins, to form both the rhodopsins (rods) and iodopsins (cones) visual 
pigments [10]. Light that enters the eyes will isomerise the bound 11-cis retinal to 
all-trans form which initiates excitation of the photoreceptor cell. This isomerisa-
tion reaction will trigger nervous signal and passes along the cranial ‘optic nerve’ 
destined for the visual centre of the cerebral cortex that translates into a picture 
[11, 12]. A vitamin A metabolite, retinoic acid (RA), is essential for the normal 
functioning of the immune system [13]. Retinol and its derivatives function as an 
immune enhancer that potentiates the antibody response; at the same time it main-
tains and restores the integration of all mucosal cells and their functions. Retinols 
are also required for the development of leukocytes that play a major role in mount-
ing an immune system. The major site of vitamin A action in the immune response 
is thought to be the T helper cell and T lymphocytes cell. The retinol derivative 
‘4-hydroxyretinoic acid’ rather than retinoic acid is important in this aspect [14].
Along with its role in vision and immune system, vitamin A has also been shown 
to be actively involved in the production of red blood cells, which are derived from 
stem cells that depend upon retinoid for their proper differentiation. Vitamin A also 
appears to facilitate the mobilisation of iron stores to the developing erythrocytes 
where it is incorporated into haemoglobin, the oxygen carrier complex protein [15]. 
In addition, vitamin A (retinol, retinoic acid, all-trans retinal) is an important signal-
ling molecule that affects gene expression and is called ‘retinoid-controlled genes’ 
which are involved in the differentiation and development of foetal and adult tissues, 
stem cell differentiation, apoptosis, support of reproductive and immune functions 
and regulation of lipid metabolism and energy homeostasis [16]. Retinol and retinoic 
acid also play a vital part in the development of human embryo and differentiation 
of three germ layers and propagation of the signalling process in the formation of the 
neural tube, organogenesis and development of limbs during embryogenesis. There 
are two main types of high-affinity receptor for trans- and cis-retinoic acid isomers 
within the nucleus cells of vertebrates including mammals. Each set of these recep-
tors has six different domains which are involved in gene expression [17].
In terms of skin health, the isoform retinoic acid will switch on genes that differ-
entiate immature skin cells into mature epidermal cells. Vitamin A and its metabolites 
have also been shown to improve photo-aged and chronologically aged skin patholo-
gies. They promote the deposition of new collagen fibres and prevent degradation 
occurring in such skin types [11]. Growth hormone is a peptide hormone that stimu-
lates growth (anabolic metabolite), cell reproduction and cell regeneration in humans 
and other animals. Growth hormone is a 191-amino acid, single-chain polypeptide 
that is synthesised, stored and secreted by the somatotropic cells within the lateral 
wings of the anterior pituitary gland. The availability of vitamin A is necessary for 
expression of many genes including those human growth hormones [11].
Studies showed that vitamin A in the form of retinol is required for maintenance 
of adult mammalian spermatogenesis. Spermatogenesis is the production and 
development of sperm. It is a process which sperm cells undergo a series of cellular 
changes and divisions in order to fully develop. The cell begins as a spermatogo-
nium and the undeveloped diploid sperm cell and ends as four spermatids. These 
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spermatids form fully developed sperm cells that comprise semen. Retinoid acid is 
an essential regulator of gametogenesis both in male and female gametes, such that 
they can enter meiosis [18]. Antioxidant activity is another identified vital role, 
where the presence of vitamin A or β-carotene in small doses showed anticancer 
effect. It appears to stem from its ability to scavenge for reactive oxygen species 
(ROS) and can improve immune function in addition to eliciting an anti-prolifera-
tive effect through the retinoic acid receptor (RAR) and retinoid X receptor (RXR). 
ROS are the most important free radical in biological system and harmful by-
products generated during the normal cellular functions. In this way, they can block 
certain carcinogenic processes and thus inhibit tumour cell growth [11, 19].
3. Assessing vitamin A status
Vitamin A status of a specific population is important to better understand 
health status of the community in that particular area. VAD can lead to many health 
consequences, with children, pregnant and lactating women known to be the promi-
nent groups suffering from VAD in many low-income countries [20]. Its prevalence 
of deficiency in a population is assessed by specific indicators/biomarkers [21].
3.1 Indicators to assess vitamin A status
There are several indicators/biomarkers to detect VAD. The ‘gold standard’ 
method to assess vitamin A status is through the direct measurement of liver 
reserves of vitamin A through biopsy, since in human, vitamin A is stored abun-
dantly (>90%) in the liver [22]. A study in average-weight individuals for 4 months 
had shown that an estimated cut-off at 0.07 μmol/g liver was able to protect them 
from any clinical signs of VAD [23]. Unfortunately, this method is not feasible for 
population evaluation [24, 25]. Therefore, other various methods are being pro-
posed to assess and monitor VAD based on their different aspects. The two different 
ways include biological (clinical, functional, histological) and biochemical indica-
tors [26]. In 2010, liver reserves of vitamin A were plotted against the commonly 
used indicators to define the range of liver reserves associated with the specific 
indicators. It was later updated in 2015 as presented in Figure 1 [27].
Figure 1. 
The definition of vitamin A status assessed by using vitamin A indicators associated with vitamin A 
concentration in the liver. In 2010, 0.7–1 μmol/g was considered adequate, but this range is considered high 
(updated in 2015) until more biologically meaningful data are generated.
Vitamin A
6
3.1.1 Biological indicators
Biological indicators consist of clinical, functional and histological components. 
The clinical indicators are xerophthalmia where it consists of two words, ‘xeros’ 
(dry) and ‘ophthalmia’ (eye), which refers to specific eye diseases caused by VAD 
[28]. It is classified into several groups with night blindness being the earliest ocular 
sign of VAD. The xerophthalmia classifications and its associated criteria of public 
health problems by WHO are highlighted in Table 2.
3.1.1.1 Functional indicators
Night blindness (XN) or poor adaptation to the dark is a functional indicator 
of VAD, which is assessed by taking a history from mothers and both pregnant 
and lactating women. The cut-off point to indicate the deficiency in mothers and 
children (age 24–71 months) is ≥1% report history of night blindness [29]. Night 
blindness occurs if vitamin A is seriously depleted since it is responsible for vision 
under very low illumination [30].
Xerophthalmia 
classifications
Symbol WHO 
criteria
Epidemiological 
aspect
Method of 
assessment
Night blindness XN >1% Difficult for 
children below 
2 years, highly 
specific, less 
sensitive
Survey/questionnaire
Conjunctival xerosis X1A Not 
applicable
Not a reliable 
indicator of 
prevalence
Clinical examinations
Bitot’s spot X1B >0.05% Common in men, 
mostly occur 
in preschool 
children. Usually 
associated with 
history of X1A and 
night blindness
Corneal xerosis X2 >0.01% A mild superficial 
haze due to 
obvious corneal 
change
Corneal ulceration/
keratomalacia (<1/3 
corneal surface)
X3A >0.01% Rapidly induced 
by VAD and 
measles infection
Corneal ulceration/
keratomalacia (≥1/3 
corneal surface)
X3B >0.1% Irreversible 
stage even with 
supplementation
Corneal scar XS >0.05% Bilateral with 
onset before 
5 years
Xerophthalmic fundus XF Not 
applicable
Rare manifestation 
of VAD
Table 2. 
Xerophthalmia classifications and its associated criteria of public health problem as per WHO (adapted from [57]).
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3.1.1.2 Clinical indicators
Signs of chronic, long-standing VAD of xerophthalmia are conjunctival xerosis 
(X1A) and Bitot’s spots with conjunctival xerosis (X1B). In general, a very bright 
torchlight in natural light is used to examine the eyes [29]. Conjunctival xerosis or 
drying can occur in both eyes where eyes turn dry and non-wettable with wrinkle 
presence at the temporal conjunctiva [31, 32]. Bitot’s spots are the accumulation of fine 
white foamy cheesy material comprising keratin, on the conjunctival surface [28].
Signs of acute, sudden onset of VAD are corneal xerosis (X2), corneal ulceration 
with xerosis (X3A), keratomalacia (X3B) and xerophthalmia fundus (XF). Corneal 
xerosis (X2) is drying of the cornea due to the lack of mucus and tears (wetting 
agent) because glands in the conjunctiva are no more functioning normally [33]. 
Lesions on the cornea become denser, and stromal oedema starts to develop during 
corneal xerosis. The cornea appears to be granular, rough and blurry when exam-
ined using a hand light [32]. At this stage, treatment with vitamin A will heal the 
eyes within 1 to 2 weeks without leaving any scars. Corneal ulceration with xerosis 
(X3A) is permanent destruction of all or some parts of the corneal stroma which 
are prominent. Ulcers may be shallow but usually become deep if it penetrates into 
the cornea. Vitamin A therapy can cure superficial ulcer, leaving small scars, while 
deeper ulcers and perforations form dense scars [28].
Keratomalacia (X3B) means softening of the cornea, and it is a rare stage of 
xerophthalmia. The cornea may become thickened and melt away due to a pro-
gression of necrosis or death of tissue, affecting the collagen in the cornea [32]. 
Blindness is usually inevitable, although other eyes and the lives of children can be 
instantly saved by vitamin A therapy. Keratomalacia is also usually associated with 
secondary eye infections but can be treated with an antibiotic [28]. Xerophthalmia 
fundus (XF) is the appearance of small yellowish lesions on the fundus of the 
eye, which occurs due to the loss of pigment from the retinal pigment epithelium 
caused by VAD. The lesions are sometimes accompanied by blind spots or scotomas, 
congruent with their distribution on the retina [34]. The healing or end result of 
corneal ulceration and keratomalacia is corneal scars (XS). Scars are left on the 
cornea with varying densities, known as staphyloma (permanent bulging of the 
damaged cornea) or phthisis bulbi (shrunken globe), whereby the contents of  
the intraocular are gone and can lead to blindness [28].
3.1.1.3 Histological indicators
The morphological changes of epithelial cells from the conjunctiva surface can 
be assessed using a piece of filter paper. Normal conjunctiva cells show an abun-
dance of mucin-secreting goblet cells and small epithelial cells. However, if there is 
a deficiency in vitamin A, the goblet cells and mucin droplets will reduce, and the 
epithelial cells become enlarged, separated and flattened [29]. Histological indica-
tors include conjunctival impression cytology (CIC) and impression cytology 
with transfer (ICT). Assessing VAD using both techniques requires standard pore 
size filter paper, slides and a simple light microscope. The method involves gently 
applying a filter paper on the surface of the conjunctiva for 2–3 seconds, and after 
removal, it is placed in fixative and stained to differentiate the goblet cells from the 
endothelial cells. The eye is classified as normal or abnormal based on the number 
of goblet cells, which is counted under a microscope [35]. The differences between 
the two techniques are ICT only require single staining while CIC include extra 
processing steps for fixing, staining and mounting specimens. Comparatively, 
the CIC technique is more efficient in transferring cells of high quality from filter 
paper to slide [29].
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3.1.2 Biochemical indicators
Biochemical indicators include serum and breast milk retinol concentrations, 
relative dose response (RDR) test, modified relative dose response (MRDR) 
test and isotope dilution (ID) assay.
3.1.2.1 Serum retinol concentrations
Serum retinol concentrations are among the most common method used 
to identify populations at risk of VAD [36]. They are determined using high-
performance liquid chromatography (HPLC). The current cut-offs for VAD are 
<0.70 μmol/L, while severe VAD is classified below 0.35 μmol/L [21]. However, 
this indicator is affected by infections [37], inflammation and inadequate intakes 
of protein, zinc or energy, which are needed for retinol-binding synthesis [38]. 
Therefore, before using serum retinol concentration to assess VAD in a population, 
these factors should also be taken into consideration. In addition, serum retinol 
concentrations are homeostatically controlled over a broad range of body store and 
only decline when the liver reserves are very low [39]. Serum retinol concentrations 
should be used in conjunction with another biological indicator or when four or 
more of the following risk factors are detected in the population being assessed 
[40]. These risk factors include:
a. Infant mortality rate and under 5 years old mortality rate are >75 of 1000  
and >100 of 1000 live births, respectively.
b. Less than 50% of children of 12–23 months old have full immunisation 
coverage.
c. The prevalence of breastfeeding in 6-month-old infants are <50%.
d. Among 75% of children (1–6 years old) have median dietary intakes <50% of 
the recommended safe levels of intake.
e. The prevalence of 2-week period of diarrhoea is ≥20%.
f. Fatality rate of measles cases is ≥1%.
g. More than 50% of women (15–44 years old) have no formal schooling.
h. Less than 50% of households has a safe water source (e.g. boiled, treated, 
filtered, properly stored).
3.1.2.2 Breast milk retinol concentrations
Breast milk retinol concentration is a unique indicator in lactating women. It has 
also been proposed as a measure of the population status of vitamin A, since the 
probability of infant and children at risk of VAD is very high if the lactating women 
are of a community with marginal vitamin A status [41]. Vitamin A deficiency is 
considered a moderate public health problem if the prevalence of inadequate milk 
retinol concentrations (≤1.05 mmol/L or ≤8 mg/g milk fat) is ≥10–<25% [29]. The 
breast milk samples are easier to obtain, and the concentration of retinol in milk 
can be determined after saponification by HPLC, similar to those used to determine 
serum retinol [42].
9Vitamin A in Health and Disease
DOI: http://dx.doi.org/10.5772/intechopen.84460
3.1.2.3 Relative dose response test (RDR)
The test principle of the RDR is on the basis that when vitamin A undergoes 
depletion, apo-retinol-binding protein (apo-RBP) accumulates in the liver. In this 
test, a challenge dose of retinyl ester is given to the subject, and blood samples are 
withdrawn prior to dosing (baseline) and 5 hours after dosing. The retinol from 
retinyl ester will bind to the excess RBP and is released into serum as holo-reti-
nol/retinol-binding protein complex (holo-RBP-retinol complex). A percentage 
change is measured as per Eq. 1 where RDR ≥ 20% indicates VAD [35].
  RDR  (%)  =   [A5] −  
[A0]  _________
 [A5] 
 × 100 (1)
where, [A5] is the serum retinol concentration at 5-hr post-dosing; and [A0] is 
the serum retinol concentration just before dosing (baseline).
3.1.2.4 Modified relative dose response test (MRDR)
MRDR is a modified test of RDR using 3, 4-didehydroretinyl acetate (DRA) 
as the challenge dose, followed by a high-fat snack to ensure adequate absorption. 
In this method, a single blood sample is taken after 4 to 7 hours dosing [43]. In 
parallel to retinyl esters, DRA is hydrolysed to 3, 4-didehydroretinol (DR) within 
small intestine, taken up by enterocytes and esterified to form various didehydro-
retinyl esters. The esters are de-esterified to form DR in the liver, which can bind 
to apo-RBP and be released into serum or can be re-esterified and stored in stellate 
cells. The only difference between DR and retinol is the presence of a double bond 
located in the 3–4 position on β-ionone ring of DR. This structural difference can be 
separated using HPLC due to their difference in polarity. The MRDR value, which 
is used to indicate liver reserves, is the ratio of DR to retinol in serum [27]. The 
ratio of 3, 4-didehydroretinol (DR) to retinol is calculated, and the value of ≥0.06 
indicates VAD in children [44]. The MRDR test has been widely used to diagnose a 
subclinical vitamin A status.
3.1.2.5 Isotope dilution (ID) assay
Of all the indicators available, the most accurate method to indirectly 
measure the vitamin A storage in the liver known till now is the isotope dilu-
tion assay [45–47]. Isotope dilution assay could detect a full range of vitamin 
A content in the body from deficient state up to the toxic level [48]. This test 
involves blood sample collection before and after the administration of a stable 
isotope tracer (deuterated or 13C-labelled retinyl acetate) at an appropriate 
equilibration period. The variations in the equation and assumptions used in the 
calculation are dependent on the study design based on the population assessed. 
The method of mass spectrometry used, the dosage size given to the subjects 
and the time allowed for equilibration were also taken into consideration when 
calculating the total body reserve in the ID test [41]. The ID assay is determined 
as shown in Eq. 2.
  ( F a × a) +  ( F b × b) =  ( F c × c) (2)
where:
a is the amount of dose absorbed and stored (dose × absorption rate).
b is the baseline total body reserves of vitamin A.
Vitamin A
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c is the total body reserve in μmol after the dose (c = a + b).
  F =  R ____ 
R + 1
and R  is 13 C  / 12 C (3)
where Fa, Fb and Fc are the abundance of isotopes [
13C/total C; At %/100;  
R/(R + 1)] from dose, baseline serum and serum after the dose.
4. Effects of vitamin A deficiency or toxicity on human health
Routine monitoring of vitamin A status serves as an important measure in the 
determination of toxicity due to excessive intake or deficiency in a population. 
Under circumstances where dietary consumption does not meet the recommended 
criteria, this could lead to vitamin deficiency or toxicity depending on whether 
the vitamin consumption is insufficient or in excess, respectively. Various health 
implications have been reported as a consequence of both vitamin deficiency and 
excess, as discussed below.
4.1 Vitamin A deficiency (VAD)
Dietary source of vitamin A is generally available in various forms, of which 
the preformed retinol from animal-based source (eggs, liver, dairy) is the most 
bioavailable form of vitamin A. Plant-based food sources are rich in pro-vitamin A; 
however, populations that are dependent solely on these sources are at higher risk 
of VAD since its absorption is reliant on various factors [49, 50]. VAD is commonly 
associated with decreased immunity and higher risk of night blindness [51]. It is 
worthwhile to note that this deficiency is highly prevalent in countries with an 
alarming increase of diabetes especially among those of lower income group in 
United States as well as Asian developing countries [51, 52].
Vulnerability to VAD differs according to specific life stages that include infancy, 
childhood and pregnancy. VAD in neonates is highly related to insufficient vitamin 
A in breast milk or formula milk. Apart from dietary shortage, VAD could have also 
been triggered by reduced intestinal absorption of vitamin A. Prolonged deprivation 
of body requirements for vitamin A leads to vitamin A deficiency disorders (VADDs) 
that affects gastrointestinal, renal, musco-skeletal organ systems as well as harming 
growth and development [53]. Xerophthalmia and anaemia are two most common 
examples of VADDs. In line with vitamin A roles as immunity enhancer, its defi-
ciency is often associated with an increased risk of infections [54, 55]. Respiratory 
tract infections and diarrhoeal diseases are the most common form of infections 
with high incidence of mortality along with marked susceptibility to severe measles 
infection [55–57]. The representation of VADD association to risk of mortality is 
presented in Figure 2 below.
4.1.1 Vitamin A deficiency and xerophthalmia
Xerophthalmia refers to a spectrum of ocular manifestations due to VAD and 
varies according to its severity and age. It is characterised by pathological dryness 
of the conjunctiva and cornea that turns out as a leading cause of childhood corneal 
blindness, especially in nutritionally deprived populations [58]. All of such signs 
encompass those involving impaired retinal sensitivity to light (night blindness) and 
epithelial disruptions of the cornea and conjunctiva (conjunctival xerosis, Bitot’s spot, 
corneal xerosis and keratomalacia) [59, 60]. The classifications of xerophthalmia 
stages in order of severity based on WHO criteria are shown in Table 2 (Section 3.1.1).
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Xerophthalmia can occur in any age group with higher possibilities in preschool-
age children, adolescents and pregnant women. In line with greater requirements for 
growth, children are more prone to VAD and xerophthalmia [61]. The initial symp-
toms of VAD are characterised by impaired adaptation to dark, which starts when the 
serum retinol concentration falls below 1.0 μmol/L and becomes more often when it 
falls lower than 0.7 μmol/L. A further drop in serum retinol concentration level below 
0.35 μmol/L leads to more frequent and severe xerophthalmia condition [62, 63]. The 
incidence of xerophthalmia is often associated with higher risk of mortality [57].
Night blindness is generally the earliest manifestation, and it is indicated by vision 
limitation under dim light and is both a sensitive and specific indicators for low serum 
retinol levels [63, 64]. Vitamin A in the form of retinal within the eyes combines with 
opsin to form rhodopsin, which is the photosensitive visual pigment of rods. Rhodopsin 
level decreases when vitamin A is deficient, and this impairs the rod function causing 
night blindness [61]. Bitot’s spot is the representation of opaque whitish deposits on 
the scleral conjunctiva, which is the most characteristic sign of problems related to 
VAD. Conjunctival xerosis is already present at this stage, with the conjunctiva appear-
ing dry and dull. Under conditions where VAD persists, corneal xerosis (hazy cornea) 
occurs, followed by keratomalacia (liquefaction of part or all cornea) [61].
Several risk factors have been associated with onset of VAD and xerophthalmia 
based on epidemiological findings. These include demographic, geographic, child-
hood, parents and household factors. The mechanism of these factor effects on the 
prevalence of xerophthalmia is summarised in Table 3.
4.2 Vitamin A toxicity
On another note, the increase in supply and consumption of fortified foods and 
supplements led to intake of preformed vitamin A at higher than the recommended 
level [75]. The side effects of vitamin A excess could occur in two forms, known as 
hypervitaminosis A and hypercarotenemia [76].
4.2.1 Hypervitaminosis A
Hypervitaminosis A can occur due to both acute and chronic intoxications that 
generally result from excessive intake of vitamin A from nutritional supplements 
Figure 2. 
Representation of VADDs in relation to risk of mortality (adapted from [53]).
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and foods rich in vitamin A [76]. Acute toxicity occurs when adults and children 
ingest more than their respective recommended dietary allowance within few hours 
or days, while chronic toxicity results from prolonged consumption of preformed 
vitamin A over the months or years. However, acute conditions create minimal 
consequences to human health compared to those under chronic toxicity [77, 78]. 
Vitamin A, being an essential fat-soluble micronutrient, is quickly absorbed upon 
ingestion, although it is only cleared slowly from the body. Under such conditions, 
toxicity could arise either from high-dose exposure or low intake over short or 
prolonged duration, respectively [79]. Chronic hypervitaminosis A leads to vari-
ous clinical manifestations that include xerosis, epistaxis, alopecia, weakness and 
fatigue, bone and joint pain, insomnia, drowsiness, anorexia, bulging fontanelle in 
infants as well as psychiatric symptoms [76].
Previous research findings have shown that elevated serum concentrations of 
vitamin A is highly associated with risk of hip fracture [80, 81]. This association 
is supported by evidence of rat-based experimental studies that demonstrated 
excessive intake of vitamin A leads to increased bone resorption and less forma-
tion at the outer surface that results in bone narrowing [82, 83]. In contrast, the 
mechanism takes place in opposing effect on the bone marrow surface, where an 
increase in vitamin A intake reduces bone resorption while increasing its formation. 
This contradictory effect takes place by the action of vitamin A or its metabolites 
on osteoblasts at the outer surface together with indirect effect on bone marrow 
surface [83, 84].
4.2.2 Hypercarotenemia
Hypercarotenemia, which is also referred to as carotenemia or carotenodermia, 
is a benign phenomenon characterised by pigmentation of the skin. The yellow-
orange pigmentation is a result of carotene deposition at the stratum corneum, 
which is the outermost layer of epidermis [76]. Hyperlipidaemia, consumption of 
excessive carotene or failure of converting carotenes into vitamin A are conditions 
that lead to the onset of carotenemia. In view that there is a direct relationship 
between β-carotene and β-lipoprotein, other medical conditions that are associated 
with hyperlipidaemia also could lead to this pigmentation. Those conditions include 
diabetes mellitus, nephrotic syndrome and hypothyroidism. Apart from these, 
patients suffering from liver disease are also at higher risk of carotenemia due to the 
Risk factors Epidemiological findings References
Demographic Higher prevalence is observed in neonates, preschool children and 
pregnant women as they are more vulnerable to be deficient
[57, 65]
Geographic VAD and xerophthalmia are generally more prevalent in rural areas due 
to variations of vitamin A-rich food sources, supplementation efforts, 
limited access and climate changes
[57, 66–68]
Childhood Breastfed children are at minimal risk of infections and xerophthalmia 
compared to the non-breastfed children
[57, 69]
Parental Education literacy is important since it is highly protective against 
xerophthalmia development and VAD in preschool children
[57, 70]
Household Poor hygiene, inefficient water supply and cultural and behavioural 
practices of a family can increase the risk of xerophthalmia. Its 
prevalence is higher in lower socioeconomic status areas
[57, 70–74]
Table 3. 
Risk factors associated with prevalence of VAD and xerophthalmia.
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impaired conversion of β-carotene into vitamin A [76]. In contrast to hypervitamin-
osis A, there are no clear indications of carotenemia to health, and the pigmentation 
could disappear within weeks to months along with a steady decrease in β-carotene 
concentration [76, 85].
4.3 Prevention of vitamin A deficiency in nutritionally vulnerable populations
Dietary factors are highly correlated with VAD, especially with increasing 
requirements at different stages of life. Apart from these, sociocultural factors 
(intra-household distribution, gender preference) and other economic constraints to 
achieve adequate dietary requirements for well-being are where a high prevalence of 
deficiency occurs that leads to prevention efforts. The undertaken prevention efforts 
should also cater to reduce infectious disease apart from improving vitamin A levels 
[53]. The prevention approach includes dietary diversification, fortification as well as 
supplementation. The feasibility of applying each preventive strategy concurrently is 
somehow dependent on deficiency prevalence and severity as well as infrastructure, 
financial capacity, potential benefits and safety [86]. In addition, it is also necessary 
to understand that the success of each preventive programme is interrelated to all 
levels, inclusive of family, community, district, national and global [53].
4.3.1 Dietary diversification
Dietary diversification refers to efforts of increasing vitamin A intake from com-
monly accessible and easily available food sources. This approach is deemed feasible 
provided there is diverse, affordable and continuous supply of vitamin A-enriched 
dietary sources. Extended breastfeeding is also regarded an important dietary inter-
vention measure, especially as a first-line defence and protection for infants and young 
children against xerophthalmia. A combined approach of weaning with a routine pro-
vision of vitamin A-enriched sources (fruits, vegetables, eggs and others) has proven 
effective in increasing serum levels of retinols among children [87]. However, under 
circumstances that the dietary supply is inadequate, home or community gardening 
will be a good alternative in ensuring food security. In addition to food security, this 
effort is viable for income generation as well as providing nutritional education to the 
community. The attempt to involve community-level participation is vital for behav-
ioural adaptation that could considerably improve vitamin A status [53].
4.3.2 Fortification
Fortified foods have been a common intervention globally in combating multiple 
nutrient deficiencies. The effectiveness of fortification-based intervention is highly 
dependent on few factors. These include the fortified food vehicle that are widely 
consumed by high-risk groups, incurs minimal cost and is of a high quality along 
with centralised processing and distribution [53]. Comparatively, preventive mea-
sure via food fortification is much more beneficial and effective than either dietary 
diversification or vitamin A capsule distribution. Numerous food sources have been 
subjected to fortification, and these range from oils, flours, cereals, rice, infant 
formula and also beverages. As such, fortification relates to exploitation of current 
fortified food consumption patterns towards enhancing vitamin A status [53].
4.3.3 Supplementation
Vitamin A supplementation at high dosage is the most widely practiced pre-
vention measures throughout the world. The supplementation is channelled on 
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an interval basis with a designated duration. This mode of prevention comprises 
community involvement and efforts to provide vitamin A supplements to nutrition-
ally vulnerable groups, especially preschool children and mothers. The rationale 
for high-dose supplementation of vitamin A is based on the assumption that this 
fat-soluble compound will be stored in the liver and is released together with the 
transport proteins as per body tissue requirement [53].
5. Conclusion
Vitamin A is one of the fat-soluble vitamins that are vital for various biological 
roles in the human body, as it is essential for embryogenesis up to adulthood. It can 
be sourced from both animal-based (preformed vitamin A) and plant-based (pro-
vitamin A) foods. The evaluation of whether a population is vitamin A deficient or 
excess is determined by status monitoring. Biological and biochemical indicators are 
the most widely applied parameters in assessment of vitamin A status. Vitamin A 
deficiency or toxicity state arises under conditions where the dietary intake does not 
comply with recommended levels. It is crucial to note that both conditions could 
lead to various health complications with VAD leading to mainly xerophthalmia, 
increased infection risk and anaemia, while toxicity could result in chronic hyper-
vitaminosis and hypercarotenemia. In line with this, prevention efforts that could 
improve vitamin A status are widely explored. Dietary diversification, fortification 
and supplementation are the three main approaches that are widely applied for this 
purpose. These continuous efforts are believed to be able in improving vitamin A 
status among the vitamin A-deficient populations.
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apo-RBP apo-retinol-binding protein
CIC conjunctival impression cytology
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